CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

Right arrow Help viewing high resolution images
Right arrow Return to article


Fig. 7. Half-life of Mdm2 mutants. U2OS cells were transiently transfected with plasmids encoding the indicated Mdm2 mutants and then incubated in medium containing [35S]methionine and [35S]cysteine. Cells were harvested at the indicated times after removal of the labeled medium, and the amount of labeled Mdm2 protein immunoprecipitated at each time point was detected by autoradiography.





Right arrow Return to article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation